Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-11-29FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc., resulting in updated labeling for the drug.
-
FDA approval · 2017-02-28FDA Approved: ROPINIROLE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s generic ropinirole under an Original Application (ANDA 204022) for indications including Parkinson's d…
-
FDA approval · 2017-01-30FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA has approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc. No specific changes are detailed in the excer…
-
FDA approval · 2017-01-23FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves an original application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2016-10-13FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-06-24FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Pramipexole dihydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2016-06-24FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals' pramipexole dihydrochloride as an original generic application, enabling a generic version of pramipe…
-
FDA approval · 2016-06-03FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc.
-
FDA approval · 2016-05-11FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
The FDA approved a supplemental application for pramipexole dihydrochloride submitted by ScieGen Pharmaceuticals Inc.
-
FDA approval · 2016-05-10FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark’s supplemental application for pramipexole dihydrochloride, authorizing a generic version of the drug.
-
FDA approval · 2016-04-28FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for pramipexole dihydrochloride from Aurobindo Pharma Limited. The drug is indicated for the treatme…
-
FDA approval · 2016-03-14FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride from Alembic Pharmaceuticals Limited. This action approves a sup…
-
FDA approval · 2016-01-10FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for ropinirole submitted by Alembic Pharmaceuticals Limited (ANDA 202786).
-
FDA approval · 2015-12-11FDA Approved: ROPINIROLE HYDROCHLORIDE — Supplemental Application (SOLCO HEALTHCARE US, LLC)
FDA approved a supplemental application for ropinirole hydrochloride from Solco Healthcare US, LLC.
-
FDA approval · 2015-12-02FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited under ANDA 202164.
-
FDA approval · 2015-11-18FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA has approved a supplemental application for ropinirole filed by Alembic Pharmaceuticals Limited.
-
FDA approval · 2015-11-17FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for ropinirole (ropinirole) in the United States. This action approves a supplemental NDA s…
-
FDA approval · 2015-10-26FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
FDA approved a supplemental application for Pramipexole dihydrochloride from ScieGen Pharmaceuticals Inc, confirming approval of a generic p…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for ropinirole from Bionpharma Inc.
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Marlex Pharmaceuticals Inc)
The FDA approved a supplemental application for ropinirole submitted by Marlex Pharmaceuticals Inc. This action authorizes changes to an alr…
-
FDA approval · 2015-10-19FDA Approved: ROPINIROLE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approved a supplemental application for ropinirole submitted by Dr. Reddys Laboratories Limited under ANDA 201576.
-
FDA approval · 2015-09-28FDA Approved: ROPINIROLE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for ropinirole, a generic ropinirole product.
-
FDA approval · 2015-09-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for pramipexole dihydrochloride (Glenmark). The approval pertains to a generic version of t…
-
FDA approval · 2015-09-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Aurobindo Pharma Limited (ANDA 202633).
-
FDA approval · 2015-09-10FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc.